Cat. No.: DIA-0243372
| Product Information | |
|---|---|
| CAS No. | 1305116-67-9 |
| Formula | C14H19ClN8OS |
| Molecular Weight | 382.87 |
| SMILES | CC1=NC(N)=C2N=NN(C[C@H]3CN(CC4=NC=CS4)CCO3)C2=N1.Cl |
| Target | Phosphodiesterase (PDE) |
| Product Description | PDE8B-IN-1 hydrochloride (compound 42) is a potent, selective PDE8B inhibitor with a IC50 value of 1.5 nM. PDE8B-IN-1 hydrochloride can be used in the study of diabetes. |
| Format & Storage | |
|---|---|
| Shipping | Room temperature in the continental U.S. Other areas may vary. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
